Bloomberg Johnson & Johnson persuaded an appeals court to throw out a $151 million award against the company over its Pinnacle artificial hips in a ruling that will affect thousands of lawsuits over the devices. A judge’s error in allowing hip recipients’ lawyers to use “highly prejudicial” evidence about bribes paid by officials of J&J units in their 2016 case ...

Bloomberg Allergan has a valuation problem and investors want to know what management is going to do about it. Shares have given up 37 percent of their value in the past nine months amid patent issues and competitive pressures. CEO Brent Saunders is sure to face questions on the company’s strategic review during Monday’s earnings call. In March, he promised ...

Bloomberg AT&T Inc. sales and earnings missed analysts’ estimates last quarter, putting additional pressure on the company to complete its Time Warner Inc. takeover and transition into a more diversified media giant. Earnings amounted to 85 cents a share in the quarter, excluding some items, the carrier said . That fell short of the average prediction of 88 cents, sending ...